Tag: Tricyclic antidepressant (chlorinated tertiary amine)

  • Clomipramine

    Tricyclic antidepressant (chlorinated tertiary amine)

    A chloro-substituted TCA with the most potent SERT inhibition in the class; the only TCA with FDA approval for OCD.

    Abstract

    Clomipramine (3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine; CAS 303-49-1; molecular formula C19H23ClN2; molecular weight 314.85) is a 3-chloro-substituted analog of imipramine developed at Geigy and approved by the FDA in 1989 under the trade name Anafranil. The chloro substitution shifts transporter selectivity sharply toward SERT (SERT Ki approximately 0.28 nM, the most potent in the TCA class; NET Ki approximately 38 nM). The active metabolite N-desmethylclomipramine (formed via CYP3A4/CYP2C19) is a NET-preferring secondary amine, producing balanced steady-state monoaminergic activity from a SERT-dominant parent. Off-target activity parallels other tertiary amine TCAs: muscarinic, H1, alpha-1, and sodium channel block. Plasma half-life is 19 to 37 hours. Used as the reference SERT-potent TCA in mechanism studies.

    FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.